Supplementary methods:
ATP release assay: In order to determine if simvastatin and control antibiotics were capable of disrupting the MRSA cell membrane, MRSA USA300 cells were treated with 5 × MIC of simvastatin, tetracycline, or lysostaphin for one hour at 37°C. DMSO was used as a negative control. Bacteria were centrifuged and supernatants were analyzed using the Enliten ATP Assay System (Promega) per the manufacturer's instructions. Aliquots (10 µl) of supernatant were mixed with 75 µl of luciferase assay reagent and the intensity of luminescence was recorded using a microplate reader (FLx800 BioTek Instruments, Inc. Winooski, Vermont).
Electron Microscopy: An overnight culture of MRSA USA300 was diluted (OD600 = 0.3) and incubated with 5 × MIC of simvastatin before samples were subsequently collected at two time points (0 and 12 hours). Samples were centrifuged and the bacterial pellets were fixed with 2.5% buffered glutaraldehyde for one hour. Cells were next treated with 1% osmium tetroxide and 1% uranyl acetate. Further dehydration was done using ethanol and embedded in white resin. The samples were stained with 1% uranyl acetate and lead citrate prior to viewing samples under a Philips CM-100 microscope 
